These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9769896)

  • 21. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
    Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
    Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
    Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
    Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality].
    Huang HQ; Jiang WQ; Wang W; Xu GC; Zhang L; He YJ; Sun XF; Zhou ZM; Liu DG; Xu RH; Lin TY; Teng XY; Liu MZ; Su YS; Li YH; Lin XB; Guan ZZ
    Ai Zheng; 2002 Dec; 21(12):1345-9. PubMed ID: 12520745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Buckstein R; Kerbel RS; Shaked Y; Nayar R; Foden C; Turner R; Lee CR; Taylor D; Zhang L; Man S; Baruchel S; Stempak D; Bertolini F; Crump M
    Clin Cancer Res; 2006 Sep; 12(17):5190-8. PubMed ID: 16951238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage therapy in Hodgkin's lymphoma.
    Byrne BJ; Gockerman JP
    Oncologist; 2007 Feb; 12(2):156-67. PubMed ID: 17296811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Total-body irradiation in non-Hodgkin's lymphomas as an alternative to chemotherapy].
    Rühl U
    Strahlentherapie; 1977 May; 153(5):299-303. PubMed ID: 327622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunotherapy strategies for non-Hodgkin's lymphomas.
    Corcoran MC; Eary J; Bernstein I; Press OW
    Ann Oncol; 1997; 8 Suppl 1():133-8. PubMed ID: 9187447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy].
    Sampi K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):951-5. PubMed ID: 3471183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted antibodies in the treatment of lymphomas.
    Falini B; Terenzi A; Liso A; Flenghi L; Solinas A; Pasqualucci L
    Cancer Surv; 1997; 30():295-309. PubMed ID: 9547998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1.
    Zhang M; Yao Z; Patel H; Garmestani K; Zhang Z; Talanov VS; Plascjak PS; Goldman CK; Janik JE; Brechbiel MW; Waldmann TA
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8444-8. PubMed ID: 17488826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunotherapy: recent results and future directions.
    Wilder RB; DeNardo GL; DeNardo SJ
    J Clin Oncol; 1996 Apr; 14(4):1383-400. PubMed ID: 8648397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term perspective of hematologic malignancies.
    Cheson BD
    Trans Assoc Life Insur Med Dir Am; 1988; 71():198-220. PubMed ID: 3285568
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiolabeled antibody therapy of lymphomas.
    Press OW; Appelbaum FR; Eary JF; Bernstein ID
    Important Adv Oncol; 1995; ():157-71. PubMed ID: 7672803
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy of leukemia and lymphoma.
    Rigberg S; Kahn SB
    Semin Drug Treat; 1973; 3(1):73-85. PubMed ID: 4715479
    [No Abstract]   [Full Text] [Related]  

  • 38. Radioimmunotherapy for acute leukemia.
    Burke JM; Jurcic JG; Scheinberg DA
    Cancer Control; 2002; 9(2):106-13. PubMed ID: 11965231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reactivation of tuberculosis in leukemias and malignant lymphomas under immunosuppressive therapy].
    Hennemann HH; Kuhn H
    Internist (Berl); 1985 Jun; 26(6):352-6. PubMed ID: 3897101
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug therapy of hematologic malignancy].
    Shimoyama M
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):337-41. PubMed ID: 8690990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.